Navigation Links
Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
Date:4/20/2011

ive tumor response has been demonstrated in a variety of cancers including liver, colon, kidney, lung and melanoma.

Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

About Liver Cancer and Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related deaths world-wide with about 660,000 patients dying from the disease annually. Most HCC cases develop on the background of chronic liver cirrhosis; in regions with the highest incidence of HCC, East Asian and African countries, the majority of cases are related to hepatitis B; in developed Western countries and Japan the disease is commonly related to hepatitis C, heavy alcohol consumption and non-alcoholic fatty liver due to metabolic syndromes such as diabetes and obesity. There is accumulating evidence that the incidence of HCC is increasing in Western countries. Despite recent advances, the treatment of advanced HCC remains a significant unmet medical need with a median expected survival under current therapies of less than one year.

About Jennerex

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two Phase 2 clinical trials in patients with primary liver cancer—an international, randomized, Phase 2 clinical trial, and a Phase 2 study of JX-594 in combination with sorafenib. Published studies designed to establish o
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
7. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
8. Jennerex Announces Presentations at Upcoming Conferences
9. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
10. Jennerex Appoints Lara Longpre to Chief Operating Officer
11. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy ... are considered the most sensitive method for detecting colorectal ... in preventing cancer cases 3 . EndoChoice ® ... Fuse™ system significantly improves the accuracy of this procedure ... colonoscopists. EndoChoice will be discussing these clinical trial results ...
(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...
(Date:5/18/2013)... Faruqi & Faruqi, LLP, a leading ... fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the ... ) The investigation focuses on ... securities laws by issuing materially false and/or misleading ... for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the investigation ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... Family Magazine of Washington DC was awarded the ... Consulting, Inc. in the category of Summer Camps in ... of the areas best in the ultimate guide on parenting, ... than Brenda Hyde, a mother of four and publisher of ... the vast resources available to them in the DC Metro ...
(Date:5/18/2013)... May 18, 2013 Although obesity is ... the association between obesity and esophageal adenocarcinoma, a type ... obesity-related tumors. As reported on Cancer.gov, last ... almost twice as likely as those of normal and ... relationship between obesity and esophageal cancer is not well ...
(Date:5/18/2013)... Rosa, CA (PRWEB) May 18, 2013 ... . The simple to read reviews and comprehensive comparisons ... and impartial home security reviews. 6Webs.com just recently finished ... alarm system providers. , Tim Smythe from 6Webs.com reports, ... security systems due to their ease of use, expandability ...
(Date:5/18/2013)... The Ayurvedic practitioner program will be offered in ... Program is available in Mexico via Live Internet or ... practiced for over 5,000 years. In Ayurvedic medicine ( ... when an individual lives in harmony with their environment, ... aims to heal an individual in all levels (physically, ...
Breaking Medicine News(10 mins):Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2
... , Chevy Chase, MD (March 18, 2011)--The growing ... earthquake and tsunami-stricken nuclear complex in Japan has ... North America from the potential plume of radioactivity ... their radiation-related health risks, the American Association of ...
... will likely be the hardest hit as a result of ... previous catastrophic events. Approximately 23 percent of Japanese citizens currently ... the highest proportion of older people in any country ... whole is headed," said James Appleby, RPh, MPH, executive director ...
... Anti-drug ads appear to be an effective way of delaying ... States, a new study has found. In 210 U.S. ... campaign, researchers analyzed the relationship between exposure to the campaign ... grades 8, 10 and 12. The campaign appeared to ...
... , FRIDAY, March 18 (HealthDay News) -- ... emergency departments are not identified as victims of abuse, ... of Pennsylvania School of Medicine analyzed court, police and ... Michigan between 1999 and 2002, and found that 80 ...
... patients who drive with cognitive impairment, according to a ... official journal of the American Gastroenterological Association (AGA) Institute. ... with cirrhosis (a condition in which the liver is ... are affected by a peculiar kind of cognitive impairment, ...
... in microfluidics could soon lead to stand-alone, self-powered chips ... by an international team of researchers from the University ... Universidad de Valparaso Chile, is able to process whole ... extra components. The researchers have dubbed ...
Cached Medicine News:Health News:Radiation risks to health: A joint statement from leading scientific experts 2Health News:Japanese tsunami underscores need for elder disaster preparedness 2Health News:Domestic Abuse Often Escapes Notice of ER Staff: Study 2Health News:Doctors should evaluate liver disease patients for cognitive impairment, address driving safety 2Health News:Doctors should evaluate liver disease patients for cognitive impairment, address driving safety 3Health News:New blood analysis chip could lead to disease diagnosis in minutes 2Health News:New blood analysis chip could lead to disease diagnosis in minutes 3
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
Medicine Products: